Porzio Third-Party Engagement is a global solution that streamlines the end-to-end process of engaging with HCP/Os, Patients, and other third parties.
With Porzio Third-Party Engagement, life sciences companies can efficiently and effectively manage any activity with HCPs, HCOs, Patients, and other high-risk parties—speaker events, advisory boards, virtual conferences, and more.
Thoughtfully designed with mobile functionality, clear approval processes, and automated workflows, Porzio Third-Party Engagement helps facilitate the end-to-end process of engaging with high-risk third parties.
Best-in-class integrations with standard connectors to more than 100 products and integration to any legacy ecosystem.
Includes built-in tiering and Fair Market Value (FMV) approval workflows using client-specific questionnaires and processes. All expert data and associated FMV values are stored and maintained on the backend of Porzio Third-Party Engagement.
When engaging experts outside their country of practice, Porzio Third-Party Engagement generates an automatic notification to the country lead for approval.
Porzio Third-Party Engagement automates background checks facilitated by the Federal OIG LEIE database. Our product notifies users during the FMV nomination phase if an expert falls on the OIG debarment list, a feature critical in avoiding CMP liability.
Interested in learning more about how the team of experts at Porzio Life Sciences can help pharmaceutical, medical device and biotechnology organizations master the evolving regulatory environment? Please reach out with any questions.
We look forward to hearing from you.